Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-I +/- Armodafinil for Insomnia and Fatigue Post-Chemotherapy
NCT01091974Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Feb 2008
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of armodafinil in Insomnia and fatigue (4 arms), sponsored by University of Rochester. Primary endpoint: Insomnia Severity Index at 9 weeks. Started Feb 2008; status: completed.
02
Drugs
armodafinil
03
Conditions
Insomniafatigue
Beyond the preview
Go deeper on NCT01091974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091974.